Hematopoietic Cell Transplant | CHOP Research Institute
 

Hematopoietic Cell Transplant

Published on
Jun 8, 2022
CHOP docs are leading IAMFIT, a clinical study testing an exercise intervention to enhance lifelong health for young HCT survivors.

Dr. Laskin's research focuses on the conduct of clinical investigations and translational studies designed to target mechanisms to prevent, treat, or slow the progression of chronic kidney disease in immunosuppressed patients, including children receiving a bone marrow or kidney transplant.

E-mail:
laskinb [at] chop.edu